The Advisory Board Company - Company Profile
Powered by 
All the data and insights you need on The Advisory Board Company in one report.
$295
- Save hours of research time and resources with
our up-to-date The Advisory Board Company Strategy Report
- Understand The Advisory Board Company position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
The Advisory Board Company (ABCO), a subsidiary of Optum, provides insight-driven performance improvement solutions and software to the healthcare community. It facilitates web-based software solutions, strategic guidance, actionable insights, management services, and implementation. The company offers services to hospitals, health care insurers, health systems, medical device companies, pharmaceutical, and biotech companies, educational institutions, commissioning and regulatory bodies. It also provides other solutions such as talent development solutions, revenue cycle solutions, and population health solutions, among others. ABCO is headquartered in Washington DC, The US.
Headquarters
United States of America
Address
655 New York Ave NW, Washington, WashingtonD.C., 20001
Website
www.advisory.com
Telephone
1 202 2665600
Industry
Business and Consumer Services
Products and Services
| Services |
|---|
| Research and Insights: |
| Cardiovascular Roundtable |
| Care Transformation Center |
| XYZ |
| XYZ |
| XYZ |
Competitor Comparison
| Key Parameters | The Advisory Board Company | MedAssets Inc | Merge Healthcare Inc |
|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America |
| City | Washington | Irving | Chicago |
| State/Province | WashingtonD.C. | Texas | Illinois |
| No. of Employees | - | - | - |
| Entity Type | Private | Private | Private |
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Anna Yakovenko | Managing Director | Executive Board | - | - |
| Alicia Daugherty | Managing Director | Executive Board | - | - |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer